Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

NCT03513549 · clinicaltrials.gov ↗
SUSPENDED
Status
10000
Enrollment
UNKNOWN
Sponsor class

Stopped Suspended due to low patient enrollment resulting from low commercial usage of Adasuve. Study continuation is impractical. Alexza has been in discussions with FDA on this matter.

Conditions

Interventions

Sponsor

Alexza Pharmaceuticals, Inc.

Collaborators